Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm
Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm
PR Newswire
NEW YORK, April 5, 2024
NEW YORK, April 5, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.
Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:
- Kinatra Therapeutics (NASDAQ: KTRA) click to participate
Kinatra Therapeutics has agreed to merge with TuHURA Biosciences. Per the terms of the agreement, Kinatra shareholders will own up to ~2.85% of the combined entity. - ARCA biopharma, Inc. (NASDAQ: ABIO) click to participate
ARCA biopharma entered into a merger agreement with Oruka Therapeutics. Upon completion of the merger, ARCA shareholders are expected to own approximately 2.38% of the combined entity. - Shockwave Medical, Inc. (NASDAQ: SWAV) click to participate
Shockwave Medical has agreed to merge with Johnson & Johnson for a cash consideration of $335.00 per share. - NuStar Energy L.P. (NYSE: NS) click to participate
NuStar Energy has agreed to be acquired by Sunoco LP for 0.400 common units per each NuStar common unit.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™
How to Get Involved:
Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation - Kuehn Law.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
SOURCE Kuehn Law, PLLC
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters